Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
08189 TEDA BIOMEDICAL
RT Nominal up0.275 +0.005 (+1.852%)
Latest  |  Final  |  Interim
Non-current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Investment Properties0--0000
Property, plant, equip. & others73,627-6.519%78,76279,57358,56156,329
Land & other Lease Assets39,309-26.231%53,28659,23767,78112,992
Intangible Assets0--12,074372,45612,297
Interests in Asso. & JCEs0--003,94813,642
Other Non-current Assets0--00012,515

112,936-21.638%144,122138,847132,746107,775
Current Assets
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Inventories90,45722.232%74,00475,22191,64288,933
Trade Receivables8,777-72.458%31,86732,08243,89259,706
Cash & Bank Balances5,934-13.449%6,85626,43913,53224,247
Other Current Assets70,420-12.355%80,34770,058111,10681,251
Assets Held for Sale14,754--04,94800

190,342-1.415%193,075208,749260,173254,138
Current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Trade Payables16,107-22.278%20,72329,53343,76819,284
S-T Debt & Leases63,262-6.100%67,37245,13111,19137,418
Other Current Liabilities127,397-2.118%130,154117,360139,35799,704
Liab asso w/ Assets Held for Sale10,076--0000

216,842-0.645%218,249192,024194,316156,406
Net Current Assets(26,500)5.265%(25,175)16,72565,85797,732
Total Assets Less Current Liabilities86,436-27.332%118,947155,572198,602205,507
Non-current Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
L-T Debt & Leases20,295-42.398%35,23445,21243,4590
Other Non-current Liabilities1,561-39.106%2,564000

21,856-42.175%37,79745,21243,4590
Capital and Reserves
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
  Share Capital189,4500.000%189,450189,450189,450189,450
  Reserves(139,499)16.893%(119,339)(88,669)(46,414)1,584
  Others0--0000
Shareholders' Funds49,951-28.754%70,111100,781143,036191,034
Non-controlling Interests14,62832.516%11,0399,57912,10814,473
Others0--0000

64,579-20.419%81,150110,359155,144205,507
Commitments and Contingent Liabilities
2023/12 - Final
RMB(K¥)
%Chg
(Compare to Final)
2022/12
RMB(K¥)
2021/12
RMB(K¥)
2020/12
RMB(K¥)
2019/12
RMB(K¥)
Commitments0--8002,403595888
Contingent Liabilities0--0000
Remarks:  Real time quote last updated: 23/12/2024 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
Security Code
Company Name (Chi/Eng/Keywords)
Industry
Profit / (Loss) Attributable to Shareholders (¥)RMB -4,123,183
%Change-63.350%
EPS / (LPS)RMB -0.002
NBV Per Share (¥)RMB 0.024
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.